QuidelOrtho (STU:QL1A) Accounts Payable: €211 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:QL1A QuidelOrtho Corp STU:QL1A
51 GF Score
Price €15.16
GF Value €32.19
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is QuidelOrtho Accounts Payable?

QuidelOrtho STU:QL1A -4.50% 51 Accounts Payable is €211 Mil as of Mar. 2026. GuruFocus rates STU:QL1A with a GF Score™ of 51/100 and a GF Value™ of €32.19 (Possible Value Trap). The stock has 8 warning signs investors should review.

QuidelOrtho's Accounts Payable for the quarter that ended in Mar. 2026 was €211 Mil.

QuidelOrtho's quarterly Accounts Payable increased from Sep. 2025 (€182 Mil) to Dec. 2025 (€239 Mil) but then declined from Dec. 2025 (€239 Mil) to Mar. 2026 (€211 Mil).

QuidelOrtho's annual Accounts Payable declined from Dec. 2023 (€270 Mil) to Dec. 2024 (€235 Mil) but then increased from Dec. 2024 (€235 Mil) to Dec. 2025 (€239 Mil).

QuidelOrtho Accounts Payable Historical Data

* Premium members only.

The historical data trend for QuidelOrtho's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho Accounts Payable Chart

QuidelOrtho Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.83 267.44 270.33 234.93 238.61

QuidelOrtho Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 213.58 189.70 182.07 238.61 210.63
STU:QL1A
51GF Score
QuidelOrtho Corp STU:QL1A
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QuidelOrtho Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €211 Mil mean?
QuidelOrtho (STU:QL1A) has a Accounts Payable of €211 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on QuidelOrtho and its competitors.
Is QuidelOrtho's Accounts Payable too high?
QuidelOrtho's current Accounts Payable is €211 Mil. Overall, QuidelOrtho has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does QuidelOrtho's Accounts Payable compare to AVR and INMD?
QuidelOrtho's Accounts Payable of €211 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on QuidelOrtho and its competitors. QuidelOrtho's current Accounts Payable is €211 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QuidelOrtho stock overvalued right now?
Based on GuruFocus' analysis, QuidelOrtho (STU:QL1A) is currently considered Possible Value Trap. The stock's GF Value™ is €32.19, compared to a current price of €15.16 — trading 52.9% below its estimated fair value. The current Accounts Payable is €211 Mil. QuidelOrtho's overall GF Score™ is 51/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For QuidelOrtho (STU:QL1A), the current Accounts Payable is €211 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is QuidelOrtho (STU:QL1A) Overvalued in 2026?

Based on GuruFocus' analysis, QuidelOrtho stock appears to be undervalued. The current stock price of €15.16 is trading 52.9% below its estimated GF Value™ of €32.19. GuruFocus considers QuidelOrtho to be Possible Value Trap.

Key valuation signals for STU:QL1A:

  • Accounts Payable: €211 Mil
  • GF Value™: €32.19 vs. price of €15.16 (52.9% below fair value)
  • GF Score™: 51/100 with 8 warning signs

No single metric tells the full story. See the STU:QL1A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

QuidelOrtho Business Description

Other Exchanges QDEL:USA0A55:UK
Address 9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
51GF Score

Get the complete analysis for STU:QL1A

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.16
Price
€32.19
GF Value